Esterase-activatable dimeric HDAC inhibitor nanotherapeutics for enhanced lymphoma epigenetic therapy. - Li T; Zhuang W; Fan S; Yi P; Ouyang G; Qian W (Colloids and surfaces. B, Biointerfaces, 2026)